雪峰科技(603227) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥1,503,536,037.67, a decrease of 13.66% compared to the same period last year[5]. - The total profit for the period was ¥222,927,592.77, down 24.78% year-on-year[5]. - Net profit attributable to shareholders was ¥161,035,191.19, reflecting a decline of 23.34% compared to the previous year[5]. - The basic earnings per share for the period was ¥0.150, a decrease of 23.48% year-on-year[6]. - Net profit for the first three quarters of 2025 was CNY 452,055,406.29, a decrease of 32.5% compared to CNY 669,415,195.51 in the same period of 2024[24]. - Operating profit for the first three quarters of 2025 was CNY 564,603,212.30, down from CNY 815,199,774.91 in 2024, representing a decline of 30.7%[24]. - The net profit excluding non-recurring gains and losses for the year-to-date was ¥160,410,230.88, down 20.55% year-on-year[5]. - The company experienced a significant decline in profit due to falling sales prices in the chemical sector, with total profit down 30.81% year-to-date[10]. - The company's operating revenue for the first three quarters of 2025 was CNY 199,077,481.44, a decrease of 44.6% compared to CNY 358,587,578.58 in the same period of 2024[35]. - The net profit for the first three quarters of 2025 was CNY 438,362,877.40, down 32.7% from CNY 652,020,219.80 in the first three quarters of 2024[36]. Cash Flow and Liquidity - The net cash flow from operating activities was ¥99,022,821.96, down 81.65% compared to the same period last year[6]. - Cash flow from operating activities for the first three quarters of 2025 was CNY 99,022,821.96, a significant decrease of 81.7% compared to CNY 539,675,120.24 in 2024[26]. - The company's cash and cash equivalents decreased to RMB 325,910,038.12 as of September 30, 2025, from RMB 1,004,198,307.54 at the end of 2024, a decline of 67.6%[18]. - Cash and cash equivalents at the end of September 2025 were CNY 285,677,500.96, down from CNY 993,230,069.03 at the end of 2024[28]. - The company reported a net cash outflow from investing activities of CNY 578,106,747.79 in the first three quarters of 2025, compared to a net outflow of CNY 78,726,381.36 in 2024[26]. - The company incurred a net cash outflow from financing activities of CNY 184,985,468.34 in the first three quarters of 2025, compared to CNY 328,240,543.02 in 2024[28]. Assets and Liabilities - Total assets at the end of the reporting period were ¥8,355,997,107.03, an increase of 5.91% from the end of the previous year[6]. - Total assets increased to RMB 8,355,997,107.03 as of September 30, 2025, up from RMB 7,889,965,320.99 at the end of 2024, representing a growth of 5.9%[19]. - Total liabilities amounted to RMB 2,306,913,022.30 as of September 30, 2025, compared to RMB 2,093,398,804.24 at the end of 2024, an increase of 10.2%[19]. - The company’s total liabilities increased, with short-term borrowings and other liabilities contributing to the rise in financial obligations[31]. - The total liabilities increased to CNY 1,169,187,604.01 in 2025 from CNY 1,091,201,760.45 in 2024, reflecting a growth of 7.1%[36]. - The company's equity attributable to shareholders reached RMB 5,085,456,690.76 as of September 30, 2025, up from RMB 4,907,054,922.32 at the end of 2024, reflecting a growth of 3.6%[21]. Research and Development - Research and development expenses increased significantly to RMB 38,948,458.66 in the first three quarters of 2025, compared to RMB 12,584,260.85 in the same period of 2024, reflecting a growth of 209.5%[22]. - Research and development expenses increased to CNY 809,262.60 in 2025 from CNY 526,199.58 in 2024, reflecting a growth of 53.7%[35]. Operational Strategy - The company is focusing on improving operational efficiency and exploring new market opportunities to enhance future growth prospects[24]. - The company reported a net profit margin decrease due to rising costs, with operating income at RMB 4,182,674,788.98 and total operating costs at RMB 3,602,566,838.39 for the first three quarters of 2025[22].